News & Press - BioFlorida, Inc.

News & Press

Read about recent events, essential information and the latest community news.

Scientific Advancements
Thursday, May 14, 2020 (0 Comments - view/add) FDA approves COVID-19 trial after successful emergency use of umbilical stem cells from RESTEM » FDA approves COVID-19 trial after successful emergency use of umbilical stem cells from RESTEM Clinical trials to begin...
Wednesday, May 13, 2020 (0 Comments - view/add) Halodine® Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19) » Halodine® Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19) FORT LAUDERDALE, Fla....
Tuesday, May 5, 2020 (0 Comments - view/add) Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19 » Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19 May 05,...
Monday, May 4, 2020 (0 Comments - view/add) NDA Filing for Potential New ADHD Treatment, KP415, Accepted by FDA; KemPharm Eligible to Receive $5 » NDA Filing for Potential New ADHD Treatment, KP415, Accepted by FDA; KemPharm Eligible to Receive $5 Million Milestone Pay...
Wednesday, April 29, 2020 (0 Comments - view/add) Chimerix, Exclusive Licensee of Cantex’ Lead Product DSTAT, has Announced Initiation of a Phase 2/3 » Chimerix, Exclusive Licensee of Cantex’ Lead Product DSTAT, has Announced Initiation of a Phase 2/3 Study of DSTAT, Fo...
Wednesday, April 29, 2020 (0 Comments - view/add) Chimerix, Exclusive Licensee of Cantex' Lead Product DSTAT, has Announced Initiation of a Phase 2/3 » Chimerix, Exclusive Licensee of Cantex' Lead Product DSTAT, has Announced Initiation of a Phase 2/3 Study of DSTAT, Former...
Wednesday, April 29, 2020 (0 Comments - view/add) TherapeuticsMD Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA® » TherapeuticsMD Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA ® -Newly-issued patent...
Friday, April 24, 2020 (0 Comments - view/add) SegAna Approved for COVID-19 Fastlane Project Pitch by National Science Foundation » SegAna Approved for COVID-19 Fastlane Project Pitch by National Science Foundation UCF Innovation Dist...
Thursday, April 23, 2020 (0 Comments - view/add) Trividia Health, Inc. Announces Launch of SARS-COV-2 Antibody Test Kit » TRIVIDIA HEALTH, INC. ANNOUNCES LAUNCH OF SARS-COV-2 ANTIBODY TEST KIT New Screening Test for COVID-19...
Wednesday, April 22, 2020 (0 Comments - view/add) Ology Bioservices to Adapt Veroplex® Cell Platform for Rapid Response to Viral Threats for Departmen » Ology Bioservices to Adapt Veroplex ® Cell Platform for Rapid Response to Viral Threats for Department of Defense...
Tuesday, April 21, 2020 (0 Comments - view/add) FDA Authorizes First Test for Patient At-Home Sample Collection » Coronavirus (COVID-19) Update: FDA Authorizes First Test for Patient At-Home Sample Collection...
Friday, April 17, 2020 (0 Comments - view/add) New Cell Therapy Trial Launches for Patients with Severe COVID-19 »
Thursday, April 16, 2020 (0 Comments - view/add) Tampa General Hospital Joins in National Research to Fight COVID-19 » Tampa General Hospital Joins in National Research to Fight COVID-19 Tampa General Hospital is one of the first hospital...
Tuesday, April 14, 2020 (0 Comments - view/add) Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19 » Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19 Companies to combine innovative...
Monday, April 13, 2020 (0 Comments - view/add) SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the Treatment of A » SECUADO ® (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the Treatment of Adults with Schizophr...
Monday, April 6, 2020 (0 Comments - view/add) Global Plasma Leaders Collaborate To Accelerate Development of Potential COVID-19 Hyperimmune Therap » Global Plasma Leaders Collaborate To Accelerate Development of Potential COVID-19 Hyperimmune Therapy...
Wednesday, April 1, 2020 (0 Comments - view/add) Limbitless transitions to making face shield parts » Limbitless transitions to making face shield parts ...
Tuesday, March 31, 2020 (0 Comments - view/add) Baptist Health Among the First Hospital Systems to Use Robots to Disinfect N95 Masks During COVID-19 » Baptist Health Among the First Hospital Systems to Use Robots to Disinfect N95 Masks During COVID-19 The goal o...
Monday, March 30, 2020 (0 Comments - view/add) Entopsis explores the use of its novel diagnostic platform, OpsisDxTM, for the detection of COVID-19 » Entopsis explores the use of its novel diagnostic platform, OpsisDxTM, for the detection of COVID-19 and triage of at-risk...
Monday, March 30, 2020 (0 Comments - view/add) Medtronic Shares Ventilation Design Specifications to Accelerate Efforts to Increase Global Ventilat » Medtronic Shares Ventilation Design Specifications to Accelerate Efforts to Increase Global Ventilator Production...
Wednesday, March 25, 2020 (0 Comments - view/add) Italian Researchers Identify New SARS-CoV-2 Gene Variants That Provide Clues to Coronavirus's Epidem » Italian Researchers Identify New SARS-CoV-2 Gene Variants That Provide Clues to Coronavirus's Epidemiology Scientists s...
Monday, March 23, 2020 (0 Comments - view/add) Cyclo Therapeutics Inc. Announces Positive Safety Profile of Its Drug Trappsol® Cyclo™ in the Treatm » Cyclo Therapeutics Inc. Announces Positive Safety Profile of Its Drug Trappsol® Cyclo™ in the Treatment of Niemann Pick Di...
Monday, March 23, 2020 (0 Comments - view/add) Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoconal Antibody f » Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoconal Antibody for Treatment, Preventi...
Monday, March 23, 2020 (0 Comments - view/add) Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoclonal Antibody » Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoclonal Antibody for Treatment, Prevent...
Saturday, March 21, 2020 (0 Comments - view/add) Scripps Research comes together to help combat the global pandemic » ...
Thursday, March 19, 2020 (0 Comments - view/add) Ridgeback Biotherapeutics and Drug Innovations Ventures at Emory Partner to Develop Clinical Stage C » Ridgeback Biotherapeutics and Drug Innovations Ventures at Emory Partner to Develop Clinical Stage Coronavirus Treatment...
Wednesday, March 18, 2020 (0 Comments - view/add) Medtronic Continuing to Increase Ventilator Production to Address COVID-19 Pandemic » Medtronic Continuing to Increase Ventilator Production to Address COVID-19 Pandemic DUBLIN, March 18, 2020 (GLOB...
Wednesday, March 18, 2020 (0 Comments - view/add) WHO to launch multinational trial to jumpstart search for coronavirus drugs » WHO to launch multinational trial to jumpstart search for coronavirus drugs By Helen Branswell @HelenBranswell...
Monday, March 16, 2020 (0 Comments - view/add) FDA quickly OKs its 2nd commercial COVID-19 test, from Thermo Fisher » FDA quickly OKs its 2nd commercial COVID-19 test, from Thermo Fisher by Conor Hale \| Mar 16,...
Monday, March 16, 2020 (0 Comments - view/add) AGTC Announces Completion of Enrollment in All Adult Dose Groups of its Ongoing Phase 1/2 Clinical T » AGTC Announces Completion of Enrollment in All Adult Dose Groups of its Ongoing Phase 1/2 Clinical Trials in Patients with...
Monday, March 9, 2020 (0 Comments - view/add) AIM ImmunoTech's Drug Ampligen to Be Tested by Japan's National Institute of Infectious Diseases as » AIM ImmunoTech's Drug Ampligen to Be Tested by Japan's National Institute of Infectious Diseases as a Potential Treatment...
Wednesday, February 26, 2020 (0 Comments - view/add) Cyclo Therapeutics Announces Completion of Enrollment in its Extension Protocol to the Phase I Trial » Cyclo Therapeutics Announces Completion of Enrollment in its Extension Protocol to the Phase I Trial to Evaluate Trappsol...
Monday, February 24, 2020 (0 Comments - view/add) Study Advances Development of Gene Therapy for x-Linked Retinitis Pigmentosa » Study Advances Development of Gene Therapy for x-Linked Retinitis Pigmentosa MIAMI , Feb. 24, 2020 /PRNewswire/...
Wednesday, February 19, 2020 (0 Comments - view/add) AGTC Announces Completion of Enrollment in the Two Highest Dose Groups of its Ongoing Phase 1/2 Clin » AGTC Announces Completion of Enrollment in the Two Highest Dose Groups of its Ongoing Phase 1/2 Clinical Trial in Patients...
Wednesday, February 12, 2020 (0 Comments - view/add) Longeveron LLC Announces Completion of Enrollment in Phase 2b Clinical Trial of Longeveron Allogenei » Longeveron LLC Announces Completion of Enrollment in Phase 2b Clinical Trial of Longeveron Allogeneic Mesenchymal Stem Cel...
View "All News Items" »

Member Sign In

Forgot your password?

Don't have a profile?